Abstract
This chapter analyzes literature data and covers main steps of evolution of ultrasound diagnosis with the use of various contrast agents. Contrast agents differ in composition, administration means, and interaction with the body. Their features determine corresponding application ways and examination types. The place of contrast-enhanced ultrasound in medical practice is discussed in depth. Individual ultrasound contrast agents are thoroughly described with special attention to advantages and disadvantages for routine diagnosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Gramiak R, Shah PM. Echocardiography of the aortic root. Investig Radiol. 1968;3(5):356–66. https://doi.org/10.1097/00004424-196809000-00011.
Shah PM. Contrast echocardiography - a historical perspective. In: Nanda NC, Schlief R, editors. Advances in echo imaging using contrast enhancement. Dordrecht: Springer; 1993. https://doi.org/10.1007/978-94-015-8126-4_1.
Lencioni R. Enhancing the role of ultrasound with contrast agents. Springer; 2006.
Chiang CW, Lin FC, Fu M, Fang BR, Hsu TS, Lee YS. Importance of adequate gas-mixing in contrast echocardiography. Chest. 1986;89(5):723–6. https://doi.org/10.1378/chest.89.5.723.
Cosgrove D, Eckersley R. Contrast-enhanced ultrasound: basic physics and technology overview. In: Lencioni R, editor. Enhancing the role of ultrasound with contrast agents. Milano: Springer; 2006.
Leopold GR, Asher WM. Deleterious effects of gastrointestinal contrast material on abdominal echography. Radiology. 1971;98(3):637–40. https://doi.org/10.1148/98.3.637.
Mattrey RF, Leopold GR, vanSonnenberg E, Gosink BB, Scheible FW, Long DM. Perfluorochemicals as liver- and spleen-seeking ultrasound contrast agents. J Ultrasound Med. 1983;2(4):173–6. https://doi.org/10.7863/jum.1983.2.4.173.
Ophir J, Parker KJ. Contrast agents in diagnostic ultrasound. Ultrasound Med Biol. 1990;16(2):209. https://doi.org/10.1016/0301-5629(90)90151-2.
Tuthill TA, Baggs RB, Violante MR, Parker KJ. Ultrasound properties of liver with and without particulate contrast agents. Ultrasound Med Biol. 1991;17(3):231–7. https://doi.org/10.1016/0301-5629(91)90044-w.
Rovai D, Lombardi M, Distante A, L’Abbate A. Myocardial perfusion by contrast echocardiography. From off-line processing to radio frequency analysis. Circulation. 1991;83(5 Suppl):III97–III103.
Weskott HP. Contrast-enhanced ultrasound. 2nd ed. London: Uni-Med Science; 2013.
Feinstein SB, Shah PM, Bing RJ, Meerbaum S, Corday E, Chang BL, et al. Microbubble dynamics visualized in the intact capillary circulation. J Am Coll Cardiol. 1984;4(3):595–600. https://doi.org/10.1016/s0735-1097(84)80107-2.
De Castro S, Agati L, Cartoni D. Harmonic imaging with Levovist for transthoracic echocardiographic reconstruction of left ventricle in patients with post-ischemic left ventricular dysfunction and suboptimal acoustic windows. J Am Soc Echocardiogr. 2000;13(2):139–45.
Drelich-Zbroja A, Jargiełło T, Szymańska A, Krzyzanowski W, Szczerbo-Trojanowska M. Can Levovist-enhanced Doppler ultrasound replace angiography in renal arteries imaging? Med Sci Monit. 2004;10(3):36–41.
Ernst H, Hahn EG, Balzer T, et al. Color Doppler ultrasound of liver lesion signal enhancement after intravenous injection of the ultrasound contrast agent Levovist. J Clin Ultrasound. 1996;24(1):31–5.
Frauscher F, Klauser A, Halpern EJ, Horninger W, Bartsch G. Detection of prostate cancer with a microbubble ultrasound contrast agent. Lancet. 2001;357(9271):1849–50. https://doi.org/10.1016/s0140-6736(00)04970-9.
Kahl A, Venz S, Keske U, Bechstein WO, Berweck S, Felix R, et al. Magnetic resonance imaging and Levovist-enhanced color and power Doppler imaging in the follow-up of pancreas transplants in patients after combined pancreas and kidney transplantation. Transplant Proc. 1998;30(2):246–7. https://doi.org/10.1016/s0041-1345(97)01244-x.
Kedar RP, Cosgrove D, McCready VR, Bamber JC, Carter ER. Microbubble contrast agent for color Doppler US: effect on breast masses. Work Progr Radiol. 1996;198(3):679–86. https://doi.org/10.1148/radiology.198.3.8628854.
Kratzer W, Reuter S, Hirschbuehl K, Ehrhardt AR, Mason RA, Haenle MM, et al. Comparison of contrast-enhanced power Doppler ultrasound (Levovist) and computed tomography in alveolar echinococcosis. Abdom Imaging. 2005;30(3):286–90. https://doi.org/10.1007/s00261-004-0263-7.
Sidhu PS, Marshall MM, Ryan SM, Ellis SM. Clinical use of Levovist, an ultrasound contrast agent, in the imaging of liver transplantation: assessment of the pre- and post-transplant patient. Eur Radiol. 2000;10(7):1114–26. https://doi.org/10.1007/s003309900117.
Spiezia S, Farina R, Cerbone G. Analysis of color Doppler signal intensity variation after levovist injection: a new approach to the diagnosis of thyroid nodules. J Ultrasound Med. 2001;20(3):223–31.
Stuhrmann M, Schwarz T, Schietzel M. Mammakarzinom-Rezidiv versus postoperative Narbe. Sonographische Differenzierung unter Einsatz des Ultraschall-Kontrastmittels Levovist [Breast cancer recurrence versus scar. Ultrasonographic differentiation using Levovist as the contrast medium]. Ultraschall Med. 2001;22(1):2–6. https://doi.org/10.1055/s-2001-11245.
Sviridov NK, Napolov IK. Klinicheskoe primenenie ul’trazvukovogo kontrastnogo sredstva levovista dlia vizualizatsii transplantata pecheni [Clinical use of the ultrasound contrast Levovist for hepatic graft visualization]. Vestn Rentgenol Radiol. 2003;(1):61–2.
Gazhonova VE, Zubarev AV, Kislyakova MV. Ekhokontrastnaya angiografiya predstatel’noj zhelezy s Levovistom dlya uluchsheniya vizualizacii krovotoka [Echocontrast angiography of the prostate with Levovist to improve the visualization of blood flow]. In: Sandrikov VA, editor. Diagnostika – novye metody [Diagnostics – new methods]. Moscow: Air-Art; 1998. p. 151–6. Russian.
Zubarev AV. 3-dementional and contrast-enhanced angiography. Meditsinskaya Vizualizatsiya. 1997;4:3–8. Russian.
Kamalov YR, Sandrikov VA, Gavrilov AV. Ispol’zovanie ul’trazvukovogo kontrasta Levovist pri obsledovanii bol’nyh opuholyami pecheni, portal’noj gipertenziej i pri ortotopicheskoj transplantacii pecheni [The use of Levovist ultrasound contrast agent in the examination of patients with liver tumors, portal hypertension, and orthotopic liver transplantation]. In: Sandrikov VA, editor. Diagnostika – novye metody [Diagnostics – new methods]. Moscow: Air-Art; 1998. Russian.
Grayburn PA, Weiss JL, Hack TC, et al. Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms. J Am Coll Cardiol. 1998;32(1):230–6. https://doi.org/10.1016/s0735-1097(98)00219-8.
Ragde H, Kenny GM, Murphy GP, Landin K. Transrectal ultrasound microbubble contrast angiography of the prostate. Prostate. 1997;32(4):279–83. https://doi.org/10.1002/(sici)1097-0045(19970901)32:4<279::aid-pros8>3.0.co;2-e.
Robbin ML, Eisenfeld AJ. Perflenapent emulsion: a US contrast agent for diagnostic radiology – multicenter, double-blind comparison with a placebo. EchoGen Contrst Ultrasound Study Group. Radiology. 1998;207(3):717–22. https://doi.org/10.1148/radiology.207.3.9609895.
Bernatik T, Becker D, Neureiter D, et al. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver. Eur J Gastroenterol Hepatol. 2004;16(3):313–7. https://doi.org/10.1097/00042737-200403000-00011.
Clark LN, Dittrich HC. Cardiac imaging using Optison. Am J Cardiol. 2000;86(4A):14G–8G. https://doi.org/10.1016/s0002-9149(00)00984-x.
Jung EM, Clevert DA, Rupp N. Erste Erfahrungen mit der kontrastmittelverstärkten Sonographie mit Optison bei der perkutanen Thermoablation von Lebertumoren [Contrast-enhanced ultrasound with Optison in percutaneous thermoablation of liver tumors]. Rofo. 2003;175(10):1403–12. https://doi.org/10.1055/s-2003-42882.
Jung EM, Jungius KP, Rupp N, et al. Contrast enhanced harmonic ultrasound for differentiating breast tumors - first results. Clin Hemorheol Microcirc. 2005;33(2):109–20.
Sontum PC. Physicochemical characteristics of Sonazoid, a new contrast agent for ultrasound imaging. Ultrasound Med Biol. 2008;34(5):824–33. https://doi.org/10.1016/j.ultrasmedbio.2007.11.006.
Ignee A, Atkinson NS, Schuessler G, Dietrich CF. Ultrasound contrast agents. Endosc Ultrasound. 2016;5(6):355–62. https://doi.org/10.4103/2303-9027.193594.
Albrecht T, Blomley M, Bolondi L, et al. Guidelines for the use of contrast agents in ultrasound. Ultraschall Med. 2004;25:249–56.
Dietrich CF, Nolsøe CP, Barr RG, Berzigotti A, Burns PN, Cantisani V, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS) in the liver - update 2020 - WFUMB in cooperation with EFSUMB, AFSUMB, AIUM, and FLAUS. Ultraschall Med. 2020;41(5):562–85. https://doi.org/10.1055/a-1177-0530.
Piscaglia F, Nolsøe C, Dietrich CF, et al. The EFSUMB guidelines and recommendations on the clinical practice of contrast enhanced ultrasound (CEUS). update 2011 on non-hepatic applications. Ultraschall Med. 2011;32:1–27.
Sidhu PS, Cantisani V, Dietrich CF, Gilja OH, Saftoiu A, Bartels E, et al. The EFSUMB guidelines and recommendations for the clinical practice of contrast-enhanced ultrasound (CEUS) in non-hepatic applications: update 2017 (long version). Ultraschall Med. 2018;39(2):e2–e44. https://doi.org/10.1055/a-0586-1107.
Summary of product characteristics. SonoVue 8 microlitres/ml powder and solvent for dispersion for injection. https://ec.europa.eu/health/documents/community-register/2015/20150619132105/anx_132105_en.pdf. Accessed 15 Feb 2021.
Piscaglia F, Bolondi L. Italian Society for Ultrasound in Medicine and Biology (SIUMB) Study Group on Ultrasound Contrast Agents. The safety of SonoVue in abdominal applications: retrospective analysis of 23188 investigations. Ultrasound Med Biol. 2006;32:1369–75.
Hu C, Feng Y, Huang P, Jin J. Adverse reactions after the use of SonoVue contrast agent. Characteristics and nursing care experience. Medicine (Baltimore). 2019;98(44):e17745.
Assessment report. SonoVue committee for medicinal products for human use (CHMP). 2 May 2014 EMA/454283/2014. https://www.ema.europa.eu/en/documents/variation-report/sonovue-h-c-303-ii-0025-epar-assessment-report-variation_en.pdf. Accessed 15 Feb 2021.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Nature Switzerland AG
About this chapter
Cite this chapter
Sencha, A.N. et al. (2022). General Aspects of the Use of Contrast Agents in Diagnostic Ultrasound. History and Current State of the Technology. Review of Contrast Agents. In: Sencha, A.N., Patrunov, Y.N. (eds) Contrast-Enhanced Ultrasound. Springer, Cham. https://doi.org/10.1007/978-3-030-91764-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-030-91764-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-91763-0
Online ISBN: 978-3-030-91764-7
eBook Packages: MedicineMedicine (R0)